Cells Reagents Supplies

Solicitation # HHSNIHOPCSBSS-21-010857 Date Posted 6-8-2021 Date Closed 6-15-2021 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price Reagent Supplies, with Biospherix Inc., Biopherix Inc reagent supplies is characterized by dysregulated cell proliferation and infiltration of activated inflammatory cells leading to progressive narrowing and obliteration of the distal pulmonary arteries. Persistent increases in pulmonary vascular resistance lead to right heart failure and ultimately death. While current therapeutics reduce pulmonary arterial pressure, and increase time to death or transplant, median survival is remains only five to seven years from the time of diagnosis. Hypoxia animal models are used in PAH. The purpose of this correspondence is to request a PO to purchase additional items to expand the Biospherix animal hypoxia system from Dr. Elinoff for PAH studies. The CCMD is establishing an animal model of PAH and the additional items are going to be use for this expansion of the current system. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, June 16, 2021 at 12:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, [email protected] by the due date and time marked in this notice.